GlobeNewswire (Mar 20, 2013)
Quote & Headlines
Market Currents
StockTalk
Today
5d
1m
3m
1y
5y
10y
52wk high:
52wk low:
EPS:
PE:
Div Rate:
Yield:
Market Cap:
Volume:
HEADLINES:
ALL
|
PRO
|
FOCUS
|
RELATED
|
TRANSCRIPTS
|
NEWS & PR
-
-
GlobeNewswire (Jul 19, 2012)
-
GlobeNewswire (Jun 19, 2012)
-
GlobeNewswire (Jun 11, 2012)
-
GlobeNewswire (Jun 7, 2012)
-
GlobeNewswire (Jun 1, 2012)
-
GlobeNewswire (May 14, 2012)
-
GlobeNewswire (Apr 30, 2012)
-
GlobeNewswire (Mar 22, 2012)
-
GlobeNewswire (Mar 13, 2012)
-
GlobeNewswire (Jan 25, 2012)
-
GlobeNewswire (Jan 17, 2012)
-
GlobeNewswire (Jan 11, 2012)
-
Spring Universal Infusion Set Listed in the 2012 Consumer Guide of the American Diabetes AssociationGlobeNewswire (Jan 4, 2012)
-
GlobeNewswire (Dec 5, 2011)
-
-
-
To learn more about Seeking Alpha Pro, click here.
-
-
-
Swings Continue in the IPO MarketIan Wyatt • Fri, Sep 3, 2010 -
IPO Returns Show VolatilityIan Wyatt • Wed, Aug 25, 2010
-
Aspen / Sigma Lead a Busy Week of Biotech DealsThe Burrill Report • Sun, Aug 22, 2010 -
-
-
Mixed Bag of IPO ReturnsIan Wyatt • Wed, Aug 4, 2010
-
There are no Transcripts on DMEDF.OB.
-
GlobeNewswire (Mar 20, 2013)
-
GlobeNewswire (Jul 19, 2012)
-
GlobeNewswire (Jun 19, 2012)
-
GlobeNewswire (Jun 11, 2012)
-
GlobeNewswire (Jun 7, 2012)
-
GlobeNewswire (Jun 1, 2012)
-
GlobeNewswire (May 14, 2012)
-
GlobeNewswire (Apr 30, 2012)
-
GlobeNewswire (Mar 22, 2012)
-
GlobeNewswire (Mar 13, 2012)
-
GlobeNewswire (Jan 25, 2012)
-
GlobeNewswire (Jan 17, 2012)
-
GlobeNewswire (Jan 11, 2012)
-
Spring Universal Infusion Set Listed in the 2012 Consumer Guide of the American Diabetes AssociationGlobeNewswire (Jan 4, 2012)
-
GlobeNewswire (Dec 5, 2011)
DMEDF.OB vs. ETF Alternatives
Company Description
We are a medical device company engaged through our subsidiaries in the research, development, manufacture and sale of innovative products for diabetes treatment and drug delivery. We have developed durable and semi-disposable insulin pumps, which continuously infuse insulin into a patient’s... More
